Formal study of large-scale production of specialty peptide drug API with continuous chromatography system announced

PeptiDream and YMC groups announce a formal joint-task group to scale successful lab work to multiple GMP production lines for specialty peptide drug products at the main factory of PeptiStar Inc. YMC’s patented twin-column technology will be a key technology in the venture. Work is anticipated to result in implementation of the technology at large scale in late 2021.